Q15025 (TNIP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: TNFAIP3-interacting protein 1 Alternative name(s): A20-binding inhibitor of NF-kappa-B activation 1 Short name=ABIN-1 HIV-1 Nef-interacting protein Nef-associated factor 1 Short name=Naf1 Nip40-1 Virion-associated nuclear shuttling protein Short name=VAN Short name=hVAN | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 636 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal; however, binding to A20/TNFAIP3 seems not to be required for this function By similarity. Inhibits NF-kappa-B activation by regulating A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG. Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcricption. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosohorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection. Ref.12 Ref.13 Ref.15 Ref.18 |
| Subunit structure | Interacts with TNFAIP3 and IKBKG; facilitates TNFAIP3-mediated de-ubiquitination of NEMO/IKBKG. Interacts with HIV-1 matrix protein. Interacts with Shigella flexneri ipah9.8; the interaction promotes polyubiquitination of IKBKG. Interacts with polyubiquitin. Interacts with MAPK1, SELPLG and PIK3CD. Interacts with IKBKG (polyubiquitinated). Interacts with IRAK1 (polyubiquitinated). Interacts with MYD88; the interaction is indicative for participation in an activated TLR-signaling complex By similarity. Ref.12 Ref.13 Ref.15 Ref.18 |
| Subcellular location | Cytoplasm. Nucleus. Note: Shuttles between the nucleus and cytoplasm in a CRM1-dependent manner. |
| Tissue specificity | Ubiquitous. Strongly expressed in peripheral blood lymphocytes, spleen and skeletal muscle, and is weakly expressed in the brain. |
| Post-translational modification | Phosphorylation at Tyr-552 by SRC-family kinases recruits phosphoinositide-3-kinase (PI3K) PIK3CD:p85 heterodimer which results in integrin activation and leukocyte adhesion to activated endothelium during inflammation. |
| Sequence caution | The sequence AAB41438.1 differs from that shown. Reason: Frameshift at positions 152 and 154. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CCNG1 | P51959 | 3 | EBI-357849,EBI-3905829 | |
| GIT2 | Q14161 | 3 | EBI-357849,EBI-1046878 | |
| IKBKG | Q9Y6K9 | 4 | EBI-357849,EBI-81279 | |
| ipaH9.8 | Q8VSC3 | 4 | EBI-357849,EBI-6125799 | From a different organism. |
| MAGEB18 | Q96M61 | 2 | EBI-357849,EBI-741835 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q15025-1) Also known as: Alpha; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q15025-2) Also known as: Beta; The sequence of this isoform differs from the canonical sequence as follows: 627-636: SPKNDREGPQ → PADLRLPRN | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q15025-3) The sequence of this isoform differs from the canonical sequence as follows: 1-53: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 636 | 636 | TNFAIP3-interacting protein 1 | PRO_0000096691 | |||||
Regions | |||||||||
| Region | 94 – 412 | 319 | Interacts with Nef | ||||||
| Region | 351 – 367 | 17 | Interaction with Shigella flexneri ipah9.8 | ||||||
| Region | 431 – 588 | 158 | Required for inhibitory activity of TNF-induced NF-kappa-B activation By similarity | ||||||
| Region | 452 – 510 | 59 | Ubiquitin-binding domain (UBD) | ||||||
| Coiled coil | 20 – 73 | 54 | Potential | ||||||
| Coiled coil | 196 – 258 | 63 | Potential | ||||||
| Coiled coil | 294 – 535 | 242 | Potential | ||||||
| Motif | 524 – 530 | 7 | Nuclear localization signal Potential | ||||||
| Compositional bias | 539 – 636 | 98 | Pro-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 403 | 1 | Phosphoserine Ref.14 Ref.16 Ref.19 | ||||||
| Modified residue | 438 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 442 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 552 | 1 | Phosphotyrosine Ref.15 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 53 | 53 | Missing in isoform 3. | VSP_045296 | |||||
| Alternative sequence | 627 – 636 | 10 | SPKNDREGPQ → PADLRLPRN in isoform 2. | VSP_003913 | |||||
| Natural variant | 103 | 1 | P → S. Corresponds to variant rs2303018 [ dbSNP | Ensembl ]. | VAR_051453 | |||||
| Natural variant | 146 | 1 | A → V. Corresponds to variant rs2233289 [ dbSNP | Ensembl ]. | VAR_051454 | |||||
| Natural variant | 151 | 1 | P → A. Corresponds to variant rs2233290 [ dbSNP | Ensembl ]. | VAR_051455 | |||||
| Natural variant | 233 | 1 | R → Q. Corresponds to variant rs2233292 [ dbSNP | Ensembl ]. | VAR_051456 | |||||
| Natural variant | 260 | 1 | A → V. Corresponds to variant rs2233295 [ dbSNP | Ensembl ]. | VAR_051457 | |||||
| Natural variant | 263 | 1 | R → W in patients with gastrointestinal diffuse large cell lymphoma. Ref.22 | VAR_067965 | |||||
| Natural variant | 286 | 1 | T → M in patients with gastrointestinal diffuse large cell lymphoma; somatic mutation. Ref.22 | VAR_067966 | |||||
| Natural variant | 374 | 1 | I → T in patients with gastrointestinal diffuse large cell lymphoma. Ref.22 | VAR_067967 | |||||
| Natural variant | 476 | 1 | E → K in patients with gastrointestinal diffuse large cell lymphoma; somatic mutation; loss of inhibitory activity on CARD11- and TNF-induced NF-kappa-B activation. Ref.22 | VAR_067968 | |||||
Experimental info | |||||||||
| Mutagenesis | 472 | 1 | D → N: Abolishes binding to polyubiquitin ('K-63'-linked and linear). Ref.18 Ref.21 | ||||||
| Mutagenesis | 552 | 1 | Y → F: Abolishes interaction with PI3K p85 regulatory subunit and abolishes interaction between SELPLG and PI3K p85 regulatory subunit. Ref.15 Ref.18 | ||||||
| Sequence conflict | 148 | 1 | G → D in AAH12133. Ref.9 | ||||||
| Sequence conflict | 178 | 1 | G → S in BAH13185. Ref.5 | ||||||
| Sequence conflict | 299 | 1 | A → P in AAG42154. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression." Fukushi M., Dixon J., Kimura T., Tsurutani N., Dixon M.J., Yamamoto N. FEBS Lett. 442:83-88(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). Tissue: Peripheral blood. |
| [2] | "A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions." Gupta K., Ott D., Hope T.J., Siliciano R.F., Boeke J.D. J. Virol. 74:11811-11824(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Leukocyte. |
| [3] | "Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1." Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S., Tabata S., Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N. DNA Res. 2:37-43(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Bone marrow. |
| [4] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). |
| [6] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Colon endothelium. |
| [7] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung. |
| [10] | "Transcriptional map of the Treacher Collins candidate gene region." Loftus S.K., Dixon J., Koprivnikar K., Dixon M.J., Wasmuth J.J. Genome Res. 6:26-34(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 136-636 (ISOFORM 2). Tissue: Craniofacial. |
| [11] | Fukushi M., Kimura T., Yamamoto N. Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 94-412. |
| [12] | "A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling." Zhang S., Fukushi M., Hashimoto S., Gao C., Huang L., Fukuyo Y., Nakajima T., Amagasa T., Enomoto S., Koike K., Miura O., Yamamoto N., Tsuchida N. Biochem. Biophys. Res. Commun. 297:17-23(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MAPK1. |
| [13] | "ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB." Mauro C., Pacifico F., Lavorgna A., Mellone S., Iannetti A., Acquaviva R., Formisano S., Vito P., Leonardi A. J. Biol. Chem. 281:18482-18488(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH IKBKG AND TNFAIP3. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "P-selectin primes leukocyte integrin activation during inflammation." Wang H.B., Wang J.T., Zhang L., Geng Z.H., Xu W.L., Xu T., Huo Y., Zhu X., Plow E.F., Chen M., Geng J.G. Nat. Immunol. 8:882-892(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SELPLG AND PIK3CD, PHOSPHORYLATION AT TYR-552, MUTAGENESIS OF TYR-552. |
| [16] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-438, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [18] | "A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response." Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. Nat. Cell Biol. 12:66-73(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SHIGELLA FLEXNERI IPAH9.8, MUTAGENESIS OF 476-GLU-ARG-477. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403 AND SER-442, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "Polyubiquitin binding to ABIN1 is required to prevent autoimmunity." Nanda S.K., Venigalla R.K., Ordureau A., Patterson-Kane J.C., Powell D.W., Toth R., Arthur J.S., Cohen P. J. Exp. Med. 208:1215-1228(2011) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITIN-BINDING, MUTAGENESIS OF ASP-472. |
| [22] | "A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma." Dong G., Chanudet E., Zeng N., Appert A., Chen Y.W., Au W.Y., Hamoudi R.A., Watkins A.J., Ye H., Liu H., Gao Z., Chuang S.S., Srivastava G., Du M.Q. Clin. Cancer Res. 17:1440-1451(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS TRP-263; MET-286; THR-374 AND LYS-476. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AJ011895 mRNA. Translation: CAA09855.1. AJ011896 mRNA. Translation: CAA09856.1. AY012155 mRNA. Translation: AAG42154.1. D30755 mRNA. Translation: BAA06416.2. AK299975 mRNA. Translation: BAH13185.1. BX640647 mRNA. Translation: CAE45793.1. AC008641 Genomic DNA. No translation available. CH471062 Genomic DNA. Translation: EAW61690.1. BC012133 mRNA. Translation: AAH12133.1. BC014008 mRNA. Translation: AAH14008.1. U39403 mRNA. Translation: AAC99999.1. U83844 mRNA. Translation: AAB41438.1. Frameshift. |
| IPI | IPI00216616. IPI00783750. |
| RefSeq | NP_001239315.1. NM_001252386.1. NP_001239319.1. NM_001252390.1. NP_001239320.1. NM_001252391.1. NP_001239321.1. NM_001252392.1. NP_001239322.1. NM_001252393.1. NP_001245383.1. NM_001258454.1. NP_006049.3. NM_006058.4. |
| UniGene | Hs.355141. Hs.731557. |
3D structure databases | |
| ProteinModelPortal | Q15025. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-27577N. |
| IntAct | Q15025. 24 interactions. |
| MINT | MINT-200912. |
| STRING | 9606.ENSP00000317891. |
PTM databases | |
| PhosphoSite | Q15025. |
Polymorphism databases | |
| DMDM | 20138952. |
Proteomic databases | |
| PaxDb | Q15025. |
| PRIDE | Q15025. |
Protocols and materials databases | |
| DNASU | 10318. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000315050; ENSP00000317891; ENSG00000145901. ENST00000389378; ENSP00000374029; ENSG00000145901. ENST00000518977; ENSP00000430971; ENSG00000145901. ENST00000520931; ENSP00000429891; ENSG00000145901. ENST00000521591; ENSP00000430760; ENSG00000145901. ENST00000522226; ENSP00000428187; ENSG00000145901. ENST00000523338; ENSP00000428243; ENSG00000145901. |
| GeneID | 10318. |
| KEGG | hsa:10318. |
| UCSC | uc003ltg.3. human. |
Organism-specific databases | |
| CTD | 10318. |
| GeneCards | GC05M150409. |
| HGNC | HGNC:16903. TNIP1. |
| HPA | HPA037893. |
| MIM | 607714. gene. |
| neXtProt | NX_Q15025. |
| PharmGKB | PA128394573. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG120932. |
| HOGENOM | HOG000253048. |
| HOVERGEN | HBG019072. |
| InParanoid | Q15025. |
| OMA | PNSRLFH. |
| OrthoDB | EOG4ZS934. |
Gene expression databases | |
| ArrayExpress | Q15025. |
| Bgee | Q15025. |
| CleanEx | HS_NAF1. HS_TNIP1. |
| Genevestigator | Q15025. |
| GermOnline | ENSG00000145901. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TNIP1. human. |
| GenomeRNAi | 10318. |
| NextBio | 35479913. |
| SOURCE | Search... |
Entry information
| Entry name | TNIP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q15025 Secondary accession number(s): B7Z699 Q9H1J3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
